Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma

Clinical Laboratory

Volumn 59, Issue 9-10, 2013, Pages 969-976

  Yahya, Raida S ^a   Ghanem, Osman H ^b   Foyouh, Abdel Aziz A ^b   Atwa, Mohamed A ^c   Enany, Sally A ^b  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b Mansoura University   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

HCC; HCV; IL 8; Oxidative stress; Trace element

Indexed keywords

ALPHA FETOPROTEIN; ANTIOXIDANT; CATALASE; GLUTATHIONE; INTERLEUKIN 8; IRON; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRACE ELEMENT; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CATALASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE; HEPATITIS C; HUMANS; INTERLEUKIN-8; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT; ZINC;

EID: 84886394837     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120712     Document Type: Article

References (42)

1. Filipowicz MS. interferon therapy of hepatitis C: Molecular insights into success and failure. Swiss Med Wkly 2010;140(1-2):3-11.
2. Blum H, Spangenberg H. Hepatocellular Carcinoma: An Update. Arch Iranian Med 2007;10(3):361-71. (Pubitemid 47162535)
3. Davis G, Dempster J, Meier J, Orr D, Walberg M, Brown B, Berger B, O'Connor J, Goldstein R (2008). Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 21(3):266-80.
4. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 2008;659-(1-2):176-84.
5. Ezzat S, Abdel-Hamid M, Eissa SA, et al. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 2005;208(5):329-39. (Pubitemid 41207425)
6. Hassan MM, Zaghloul AS, El-Serag HB, et al. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 2001;33(2):123-6. (Pubitemid 32685921)
7. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncology 2005;7(2):122-33. (Pubitemid 40590513)
8. Mukaida N, Morita M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994;269:13289-95.
9. Rutkowski P, Kaminska J, Kowalska M, Ruka W, Steffen J. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinicopathological features and prognosis. Int J Cancer 2002;100:463-71.
10. Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM. Clinicobiological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia. Haematologica 1999;84:208-11. (Pubitemid 29476922)
11. Retzlaff S, Padro T, Koch P, et al. Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma. Oncol Rep 2002;9:525-7.
12. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001;19:577-83. (Pubitemid 32112873)
13. Zekri AR, Alam El-Din HM, Bahnassy AA, et al. Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4. Comparative Hepatology 2010;9(1):1.
14. Kubo F, Ueno S, Hiwatashi K, et al. Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. Ann Surg Oncol 2005;12:-800-7.
15. Seregni E, Botti C, Bombardieri E. Biochemical characteristics and clinical applications of alpha-fetoprotein isoforms. Anticancer Res 1995;15(4):1491-9.
16. Taylor AM, and Byrd PJ (2005). "Molecular pathology of ataxia telangiectasia". J. Clin. Pathol. 58 (10): 1009-15. (Pubitemid 41416047)
17. De Maria N, Colantoni A, Fagiuoli S, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21(3):291-5. (Pubitemid 26271718)
18. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MMC, Ou JH. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 2004;39:81-9. (Pubitemid 38461470)
19. Saracoglu S, Tuzen M, Soylak M. Evaluation of trace element contents of dried apricot samples from Turkey. Journal of Hazardous Materials 2009;167:647-52.
20. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36:S35-46. (Pubitemid 35253462)
21. Tran G. The role of hepatitis C virus in the pathogenesis of hepatocellular carcinoma. Bioscience Horizons (2008)1(2):167-75.
22. Tilg H, Kaser A. How to modulate inflammatory cytokines in liver diseases. Liver International 2006;26(9):1029-39. (Pubitemid 44541743)
23. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 1997;50:401-6. (Pubitemid 27278444)
24. Levent G, Ali A, Ahmet A, et al. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. Journal of Translational Medicine 2006;4:25.
25. Choi J, James Ou J-H. Mechanisms of Liver Injury.III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006;290: G847-G851.
26. Braticevici CF, Mohora M, Creţoiu D, et al. Role of oxidative stress in the pathogenesis of chronic hepatitis C (CHC). Romanian Journal of Morphology and Embry ology 2009;50(3):407-12.
27. Osman HG, Gabr OM, Lotfy S, Gabr S. Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian Journal of Medical Microbiology 2007;25(4):323-9.
28. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003;34:1-10. (Pubitemid 36043881)
29. Lin CC, Yin MC. B vitamins deficiency and decreased antioxidative state in patients with liver cancer. Eur J Nutr 2007;46:293-9.
30. Min JY, Lim SO, Jung G (2010). Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Letters 584:2427-32.
31. Hadi YM, Kacmaz M, Öztürk HS, Durak J. Antioxidant status of erythrocytes from patients with cirrhosis. Hepatogastroenterolog 1999;46:2460-8.
32. Yasuyama T, Inoue K, Kojima T, Sasaki H. Activities, electrophoretic profiles and immunolocalization of superoxide dismutase in human liver specimens. Jpn J Med 1988;27:34-41.
33. Mastoi AA, Devrajani BR, Rahopoto Q, Memon SA, Qureshi GA. Anti-Oxidant Activity and Metabolic Disturbances in Hepatitis C Patients with or without Diabetes Mellitus. World Applied Sciences Journal 2009;7(8):971-7.
34. Kato J, Miyanishi K, Kobune M, Nakamura T, Takada K, Takimoto R. Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol 2007;42:830-6. (Pubitemid 47617461)
35. Sayed HA, El Ayyat A, El Dusoki H, et al. A cross sectional study of hepatitis B, C, some trace elements, heavy metals, aflatoxin B1 and schistosomiasis in a rural population, Egypt. J Egypt Public Health Assoc 2005;80(3-4):355-88.
36. Mihm U, Herrmann E, Sarrazin U, et al. Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C. Journal of Hepatology 2004;40:845-52. (Pubitemid 38507367)
37. Tachibana Y, Nakamoto Y, Mukaida N, Kaneko S. Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C. Cancer Letters 2007;251(1):36-42. (Pubitemid 46589764)
38. Polyak SJ, Khabar KSA, Rezeiq M, Gretch DR. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 2001;75:-6209-11.
39. Ren Y, Poon RT, Tsui HT, et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 2003;1:-5996-6001.
40. El-Tayeh SF, Hussein TD, El-Houseini ME, Amer MA, El-Sherbini M, Elshemey WM. Serological biomarkers of hepatocellular carcinoma in Egyptian patients. Dis Markers 2012;32(4):255-63.
41. Arrieta O, Cacho B, Espinosa DM, Villavicencio AR, Estrada DF, Pedro NH. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer 2007;7:28.
42. Baig JA, Alam JM, Mahmood SR, et al. Hepatocellular carcinoma (HCC) and diagnostic significance of α-fetoprotein (AFP). J Ayub Med Coll Abbottabad 2009;21(1):72-5.